Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MGAM | O43451 | 2/20 | 0.40 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | SI | P14410 | 2/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.40 |
| ▸ | F12 | P00748 | 2/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19092972 | 0.82 | KCNMA1 (0.61) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL12204268 | 0.74 | KCNMA1 (0.51) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL5964502 | 0.73 | POLB (0.45) | KMT2APOLBMGAMAMY1AGAA | |
| SCHEMBL2395074 | 0.73 | KCNMA1 (0.49) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL13618757 | 0.69 | KDM4E (0.47) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL16882633 | 0.69 | ALDH1A1 (0.51) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL20156571 | 0.69 | GAA (0.47) | KMT2AKCNMA1MGAMAMY1AGAA | |
| SCHEMBL20637702 | 0.69 | KCNMA1 (0.55) | KMT2AKCNMA1POLBMGAMAMY1A | |
| SCHEMBL13722960 | 0.68 | KCNMA1 (0.44) | KMT2AKCNMA1MGAMAMY1AGAA | |
| SCHEMBL20156511 | 0.68 | GAA (0.49) | KMT2AKCNMA1MGAMAMY1AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060264672-A1 | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264672-A1 | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | ALOX5, GSTO1, FASN | KMT2A 3311/4885KCNMA1 1397/4885POLB 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.